Search results
Results from the WOW.Com Content Network
It was established as Clinical Lymphoma in 2000, renamed to Clinical Lymphoma & Myeloma in 2005 and obtained its current name in 2010. The journal covers research on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia, and related disorders, including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias.
Clinical Nursing Research is a peer-reviewed nursing journal covering the field of clinical nursing. The editor-in-chief is Melissa D. Pinto ( Mayo Clinic ). It was established in 1992 and is published by SAGE Publications eight times a year.
Cancer Chemotherapy and Pharmacology is a peer-reviewed medical journal covering oncological pharmacotherapy. It was established in 1978 and is published by Springer Science+Business Media. The editors-in-chief are Jan Hendrik Beumer (University of Pittsburgh School of Pharmacy) and Étienne Chatelut (Institut Claudius-Regaud).
EPOCH is an intensive chemotherapy regimen intended for treatment of aggressive non-Hodgkin's lymphoma. [1] [2] It is often combined with rituximab. In this case it is called R-EPOCH or EPOCH-R. The R-EPOCH regimen consists of: Rituximab: an anti-CD20 monoclonal antibody, which has the ability to kill B cells, be they normal or malignant;
In order to develop more effective first-line chemotherapy regimen for aggressive lymphomas, some researchers tried to add toposide to the standard [R]-CHOP regimen. [7] There were also attempts to further improve the efficacy of the [R]-CHOEP regimen with escalating the chemotherapy doses. This mode was called [R]-High-CHOEP. However, it did ...
As of 2008, research in this area is active. [ 27 ] Another avenue for novel anti-cancer therapies is re-engineering some of the currently used conventional antibodies like trastuzumab (targeting HER2/neu ), cetuximab and panitumumab (both targeting the EGF receptor ), using the BiTE approach.
Leukemia & Lymphoma is a peer-reviewed medical journal published by Informa Healthcare. It covers basic and clinical aspects of hematologic malignancies (leukemias and lymphomas). The editors-in-chief are Aaron Polliack (Hadassah University Hospital), Koen Van Besien (Weill Cornell Medical Center), and John Seymour (Peter MacCallum Cancer Centre).
Nursing journals remain a primary method in which the nursing community shares information and disseminates research findings. These journals are most often peer-reviewed and contain editorials and reports of original research, including randomized controlled trials , observational studies , systematic reviews , meta-analyses , and qualitative ...